×
About 186 results

ALLMedicine™ Noncardiac Chest Pain Center

Research & Reviews  93 results

Emergency Department Clinician Experiences and Perceptions Regarding Noncardiac Chest P...
https://doi.org/10.1016/j.jmpt.2019.02.004
Journal of Manipulative and Physiological Therapeutics; Gelley G, Zarrabian M et. al.

Apr 28th, 2019 - The objectives of this study are to report the responses of emergency department (ED) clinicians regarding the characteristics and management of patients with noncardiac chest pain (NCCP) and to explore clinician experiences with the current stand...

Sustained esophageal longitudinal smooth muscle contraction may not be a cause of nonca...
https://doi.org/10.1111/nmo.13428
Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society; McIntosh K, Paterson WG

Aug 2nd, 2018 - The etiology of noncardiac chest pain (NCCP) is poorly understood. Some evidence suggests that it may be related to sustained esophageal contractions (SECs) of longitudinal smooth muscle. This study attempts to evaluate whether SECs play a role in...

Jackhammer Esophagus: Symptom Presentation, Associated Distal Contractile Integral, and...
https://doi.org/10.1097/MCG.0000000000001021
Journal of Clinical Gastroenterology; Sloan JA, Mulki R et. al.

Mar 9th, 2018 - The aim of our study was to characterize jackhammer esophagus symptoms and their relationship with the distal contractile integral (DCI) and bolus transit. Jackhammer esophagus is defined by the Chicago Classification version 3.0. This diagnosis i...

Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the manage...
https://doi.org/10.1097/MEG.0000000000000925
European Journal of Gastroenterology & Hepatology; Viazis N, Katopodi K et. al.

Jun 19th, 2017 - Although gastroesophageal reflux disease is the main cause of noncardiac chest pain (NCCP), proton pump inhibitors (PPIs) benefit a minority of patients. Our prospective study evaluated the effect of PPI and selective serotonin reuptake inhibitors...

Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)
https://clinicaltrials.gov/ct2/show/NCT00219492

Jun 19th, 2017 - Key Objectives: To determine the density and activation of esophageal mast cells in non-cardiac chest pain patients. We expect to find mast cell activation, as measured by mast cell count or degranluation, tryptase staining, and histamine release,...

see more →

Clinicaltrials.gov  93 results

Emergency Department Clinician Experiences and Perceptions Regarding Noncardiac Chest P...
https://doi.org/10.1016/j.jmpt.2019.02.004
Journal of Manipulative and Physiological Therapeutics; Gelley G, Zarrabian M et. al.

Apr 28th, 2019 - The objectives of this study are to report the responses of emergency department (ED) clinicians regarding the characteristics and management of patients with noncardiac chest pain (NCCP) and to explore clinician experiences with the current stand...

Sustained esophageal longitudinal smooth muscle contraction may not be a cause of nonca...
https://doi.org/10.1111/nmo.13428
Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society; McIntosh K, Paterson WG

Aug 2nd, 2018 - The etiology of noncardiac chest pain (NCCP) is poorly understood. Some evidence suggests that it may be related to sustained esophageal contractions (SECs) of longitudinal smooth muscle. This study attempts to evaluate whether SECs play a role in...

Jackhammer Esophagus: Symptom Presentation, Associated Distal Contractile Integral, and...
https://doi.org/10.1097/MCG.0000000000001021
Journal of Clinical Gastroenterology; Sloan JA, Mulki R et. al.

Mar 9th, 2018 - The aim of our study was to characterize jackhammer esophagus symptoms and their relationship with the distal contractile integral (DCI) and bolus transit. Jackhammer esophagus is defined by the Chicago Classification version 3.0. This diagnosis i...

Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the manage...
https://doi.org/10.1097/MEG.0000000000000925
European Journal of Gastroenterology & Hepatology; Viazis N, Katopodi K et. al.

Jun 19th, 2017 - Although gastroesophageal reflux disease is the main cause of noncardiac chest pain (NCCP), proton pump inhibitors (PPIs) benefit a minority of patients. Our prospective study evaluated the effect of PPI and selective serotonin reuptake inhibitors...

Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)
https://clinicaltrials.gov/ct2/show/NCT00219492

Jun 19th, 2017 - Key Objectives: To determine the density and activation of esophageal mast cells in non-cardiac chest pain patients. We expect to find mast cell activation, as measured by mast cell count or degranluation, tryptase staining, and histamine release,...

see more →